DOCS Jan 2024 35.000 put
| Previous close | 5.50 |
| Open | 5.00 |
| Bid | 5.90 |
| Ask | 6.20 |
| Strike | 35.00 |
| Expiry date | 2024-01-19 |
| Day's range | 5.00 - 5.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 102 |
Motley Fool2 Magnificent Growth Stocks to Buy With $100 Right Now
Almost anyone can get their money to start working for them with investments in these game-changing businesses.
Business WireDoximity Announces New Workflow Products, Long-Term Financial Targets at Inaugural Investor Day
SAN FRANCISCO, June 06, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new physician workflow products and long-term financial targets during its inaugural Investor Day at the New York Stock Exchange.
Motley Fool3 Top Healthcare Stocks to Buy for June
No matter what the economy is doing, healthcare stocks make a great long-term bet. Intuitive Surgical (NASDAQ: ISRG) is the global leader in robotic surgery. Today, Intuitive has an installed base of more than 7,700.
Simply Wall St.Slowing Rates Of Return At Doximity (NYSE:DOCS) Leave Little Room For Excitement
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...
Motley Fool2 Soaring Healthcare Stocks That Could Climb Even Higher
Veeva Systems (NYSE: VEEV) is a cloud-based software provider to pharmaceutical companies and other members of the highly regulated life-science industry. Generally, biotechnology start-ups use Veeva Vault applications to keep track of data collected from laboratory research and clinical trials. Companies with approved drugs to sell tend to bundle Vault with Veeva's customer relationship management (CRM) products.
PR NewswirePalo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Tuesday, June 20, to coincide with the quarterly rebalance. The U.S. equity markets will be closed on Monday, June 19 in observance of the Juneteenth holiday. The changes ensure each index is more representative of its market capitalization range. All companies moving to the S&P MidCap 400 are more representative of the mid-cap m
Motley Fool3 Things Investors Will Love About Doximity (and 1 They Won't)
Doximity (NYSE: DOCS) was viewed as an exciting, fast-growing telehealth company when it went public in 2021. Here's a look at three reasons why Doximity makes for an attractive investment, as well as a potentially important reason to hold off on adding the stock to your portfolio right now. One of the most important numbers for growth-oriented companies is the revenue retention rate, which tells you how much more (or less) customers are spending with a business compared to the previous year.
Motley FoolBetter Healthcare AI Stock: Moderna vs. Doximity
The AI in healthcare market is expected to top $100 billion by the end of the decade, and some companies are already leveraging this technology to advance their work. Two great examples are Moderna (NASDAQ: MRNA) and Doximity (NYSE: DOCS). Moderna isn't a novice when it comes to AI.
Motley Fool1 No-Brainer Stock to Buy With $100 Right Now
After doubling on its first day of trading and nearly doubling again in the next few months, shares of Doximity (NYSE: DOCS) have been on a steady march downward -- losing over 70% of its value from its all-time highs. Doximity's stock was caught in the all-too-common trap of initial public offering (IPO) hype, followed by a year or more of turbulence as the business settled into being a public company. This divergence between share price and operational performance leaves us wondering: Is now the time to buy Doximity at roughly 35% above its all-time lows?
ZacksDoximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Business WireDoximity to Present at the William Blair 43rd Annual Growth Stock Conference
SAN FRANCISCO, May 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Dr. Nate Gross, co-founder and chief strategy officer, will present at the William Blair 43rd Annual Growth Stock Conference on Thursday, June 8, 2023 at 10:00 a.m. Central Time.
Motley Fool2 Growth Stocks Billionaires Keep Buying Hand Over Fist
The next time you go looking for the best possible growth stocks to buy, remember that you don't have to reinvent the wheel every time. Every three months, the U.S. Securities and Exchange Commission (SEC) makes just about anyone with over $100 million under management report their trading activities and the latest round of quarterly disclosures. Billionaire Steven Cohen and the fund he manages, Point72, bought nearly 675,000 shares of Doximity (NYSE: DOCS) in the first quarter.
Motley FoolSaaS Stocks Aren't Out of the Woods Just Yet
Mixed results from software platform providers show the jury's still out on the business model's viability.
ZacksDoximity (DOCS) Q4 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of 17.65% and 0.78%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireDoximity Announces New Integration with MEDITECH
SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced an integration with MEDITECH, one of the most widely used electronic health record (EHR) systems in the United States. The integration enables medical professionals to launch a Doximity Dialer voice or video telehealth visit directly from MEDITECH’s physician-facing native app, Expanse Now.
Business WireDoximity Announces Fourth Quarter and Fiscal Year 2023 Financial Results and New Senior Leadership Hires
SAN FRANCISCO, May 16, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2023 fourth quarter and fiscal year ended March 31, 2023. The company also announced the appointment of two new senior leadership members, Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products.
ZacksNutex Health Inc. (NUTX) Reports Q1 Loss, Tops Revenue Estimates
Nutex Health Inc. (NUTX) delivered earnings and revenue surprises of 50% and 1.49%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Doximity, Inc. (NYSE:DOCS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Doximity's (NYSE:DOCS) recent performance, when its stock has declined 3.8...
ZacksCharles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
Charles River (CRL) delivered earnings and revenue surprises of 7.34% and 4.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Motley Fool3 Best Stocks to Buy in May and Hold Forever
In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever.
ZacksAgilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates
Agilon (AGL) delivered earnings and revenue surprises of 33.33% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireDoximity to Release Fiscal 2023 Fourth Quarter Results on May 16, 2023
SAN FRANCISCO, April 25, 2023--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter ended March 31, 2023 after market close on May 16, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
- Zacks
ELV or DOCS: Which Is the Better Value Stock Right Now?
ELV vs. DOCS: Which Stock Is the Better Value Option?
- Business Wire
Doximity Releases New Study on Physician Compensation and Impact of Overwork and Economic Pressures
SAN FRANCISCO, March 23, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its annual Physician Compensation Report, revealing a slight decline of 2.4% in average pay for doctors in 2022. The report includes self-reported compensation data from over 190,000 U.S. doctors over six years and over 31,000 full-time physicians in the last year alone.
Business WireDoximity to Host Inaugural Investor Day June 6, 2023
SAN FRANCISCO, March 21, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will host an Investor Day on Tuesday, June 6, 2023. The event will be held at the New York Stock Exchange in New York City from 10:30 a.m. to 1:30 p.m. Eastern Time.
